top of page

Search Results

Search this site

191 results found

  • From Bleeding Gums to Brilliant Smiles

    Introduction  The oral cavity supports complex microbial communities that play a crucial role in both oral and systemic health. When this balance is disrupted, it can lead to conditions such as gingivitis and periodontitis. Certain species, particularly Porphyromonas gingivalis , act as pathogens that promote disease progression even at low abundance. Oral biofilm development follows a structured sequence, beginning with early colonizers such as Streptococcus , which alter local conditions and enable later colonization by more pathogenic bacteria like Fusobacterium nucleatum . These shifts create anaerobic environments that support inflammation, tissue damage, and tooth loss. Increasing evidence also links periodontal disease to systemic conditions, including cardiovascular disease, diabetes, neurodegenerative disorders, and chronic kidney disease, largely through persistent inflammation and the spread of bacterial components into the bloodstream (Ramji et al. , 2025). To better understand these complex interactions, multi-omics approaches, integrating genomic, transcriptomic, proteomic, and metabolomic data, are increasingly being applied to oral health research. These methods have revealed associations between microbial composition, host responses, and disease progression, while also enabling the identification of biomarkers in oral fluids and tissues (Ramji et al. , 2025). Together, they provide a more comprehensive framework for evaluating disease mechanisms and guiding the development of targeted, evidence-based oral care interventions  Article:   Multi-Omics Insights into Gingivitis from a Clinical Trial: Understanding the Role of Bacterial and Host Factors (Ramji et al.,  2025) Using a multiomics approach combining salivary proteomics with microbial composition analysis, this 8-week study sought to investigate the effects of a stannous fluoride-containing toothpaste on oral microbiome composition, and host biomarker responses, in a cohort of patients divided into individuals with (high bleeders) or without (low bleeder) gingivitis to better understand the both molecular mechanisms by which this ingredient is able to influence microbiome structure and function, and its interactions with host tissues of the oral cavity, with particular emphasis on the supragingival region (Ramji et al. , 2025). Results Significant differences were observed between high and low bleeders at baseline, with the former possessing a greater abundance of bacterial genera associated with gingivitis, like Porphyromonas, Fusobacterium, and Alloprevotella  that were positively correlated with clinical measures like gingival inflammation and bleeding. However, after 4-weeks of stannous fluoride-containing toothpaste use, changes in the abundance of 17 bacterial genera were recorded. Compositional shifts that involved a significant decrease in the relative abundance of Porphyromonas ,   and significant increase in the relative abundance of commensal genera such as Rothia and Haemophilus , aligned with improved clinical signs like decreased bleeding and inflammation. These observations point to stannous fluoride as an effective treatment for unhealthy gingival microbiomes, where it works to promote growth of beneficial bacteria over pathogens, which could, in turn, reduce symptoms associated with gingivitis, like inflammation and oxidative stress. Proteomic analysis of saliva samples at baseline revealed a total of 192 host proteins displaying differential expression between the high and low bleeder group. Further enrichment analysis of these proteins showed biological processes such as tissue homeostasis and antimicrobial defence responses were downregulated in the high bleeders, rendering the oral cavity more susceptible to pathogen colonisation and impairing healing. On the other hand, processes related to immune system activity, response to stress, inflammatory response, and response to oxidative stress were upregulated, with this combination of processes possibly working to induce a dysregulated, pro-inflammatory oral environment that facilitates tissue destruction and disease progression. Of these 192 proteins, 71 were identified as host proteomic disease biomarkers of gingivitis. However, following 8-weeks of treatment with the stannous fluoride toothpaste, 29 of the proteins showed treatment-induced shifts from disease towards a healthier state. Other groups of proteins with improved expression included 69 (of the 192) proteins involved in antimicrobial responses, cell stress responses, and immune system processes that were downregulated after treatment, thus demonstrating the ability of stannous treatments to modulate immune activity, and reduce inflammation within the host oral environment to support improved tissue health and resilience. Collagen breakdown is a process associated with clinical markers like bleeding and gingival inflammation, as was observed at significantly higher proportions in the high-bleeder group than the low bleeder one. However, consistent use of the stannous fluoride toothpaste over the 8-week trial period was enough to result in a significant reduction in oral collagen breakdown and associated clinical markers in high bleeders. This result may be attributed to stannous fluoride’s ability to inhibit the activity of bacterial collagenase enzymes in pathobionts like F. nucleatum and P. gingivalis , which work to degrade host collagen tissue in the gingival region to cause physiological effects such as sagging, thus promoting preservation of oral tissue integrity (Ramji et al. , 2025). Conclusion Using an integrated multiomics approach, this study was able to provide a comprehensive overview of how a stannous fluoride toothpaste treatment can positively influence microbial community structure and metabolite profiles by reducing abundance of pathogenic bacteria, like Porphyromonas and Fusobacterium , and promoting growth of beneficial commensals such as Rothia and Haemophilus in individuals exhibiting clinical signs of gingivitis. These changes are also associated with reductions in the expression of disease biomarkers and proteins involved in processes like inflammation, oxidative stress, and tissue damage, while simultaneously improving the structural integrity of oral tissues that occur as a result of collagen breakdown (Ramji et al. , 2025). Strengths and Limitations of Research Strengths The use of multiomics approaches to examine the complex interplay between the microbiome, oral environment, and associated metabolites, can be used to facilitate the identification of specific microbial and metabolic biomarkers that can be used to monitor and track changes in oral health, paving the way for preventive care measures as well as informing the development of targeted therapeutic approaches with improved individual biocompatibility and minimal side effects to mitigate against disease-related changes (Ramji et al. , 2025). Limitations There are still very few multiomics studies available looking at the effects of oral care products on oral health as there is a relatively new focus on this type of research. As a result, our understanding of their effects on microbiome function remain limited, making it difficult to draw absolute conclusions regarding the effectiveness of certain products or oral care ingredients at promoting a healthy microbial community composition and function. Future Directions and Research Future integration of multiomics technologies (e.g., genomic, transcriptomic, proteomic, and metabolomic data) systems biology, and synthetic biology may work to more effectively draw a link between microbial genes and different natural products, essentially allowing prediction of metabolites derived from the single microbe or community level, and facilitating the discovery of novel active molecules that can be used to drive product formulation for both cosmetic and therapeutic oral applications (Wu et al. , 2024).  Conclusion Together, advances in multi-omics research are transforming how oral health is understood and managed by revealing the complex interactions between microbial communities, host biology, and clinical outcomes. By moving beyond surface-level observations to capture functional and molecular changes, this approach provides a more precise framework for evaluating oral care ingredients, identifying important biomarkers, and supporting evidence-based product development. As this field continues to evolve, integrated biological insights will be essential for designing targeted, effective oral care solutions that promote long-term health, resilience, and disease prevention. References Ramji, N. et al.  (2025) ‘Multi-Omics Insights into Gingivitis from a Clinical Trial: Understanding the Role of Bacterial and Host Factors’, Microorganisms , 13(10), p. 2371. Available at:   https://doi.org/10.3390/microorganisms13102371 . Wu, S. et al.  (2024) ‘Multi-omic analysis tools for microbial metabolites prediction’, Briefings in Bioinformatics , 25(4), p. bbae264. Available at:   https://doi.org/10.1093/bib/bbae264 .

  • One Routine. Two People. Two Very Different Results.

    Many people assume there is a single “healthy” or “perfect” microbiome to aim for, but in reality no two microbiomes are alike. Your skin’s microbiome is shaped by genetics, environment, ethnicity, lifestyle, hormones and even climate. Even people with the same skin type or routine can show distinct microbial profiles. What keeps one person’s skin balanced may do little for another, and in some cases can trigger disruption. What We Know: Research shows that: A healthy microbiome is better defined by how well it stays balanced and adapts to change (Prajapati et al, 2025).  People living in different regions, climates or environments can have entirely different microbiome compositions while remaining clinically healthy (Gupta et al, 2017).  Higher diversity is not automatically better—some healthy skin areas naturally have low diversity (Lloyd-Price et al, 2016).  Two people using the same product may have different outcomes because their microbiomes influence how that product behaves (Hwang et al, 2021).  Industry Impact And Potential: The absence of a “universal” microbiome profile fundamentally changes how skincare should be developed. This opens new strategic opportunities for brands to innovate beyond one-size-fits-all approaches, including: Creating routines built around baseline microbiome profiles, not generic skin types. Identifying “microbiome responders” and “non-responders,” helping refine targeting and reduce irritation-related returns. Developing demographic-specific formulations shaped by ethnicity, environment, hormonal phase or age. Strengthening claim credibility using measurable biological outcomes rather than assumed skin benefits. Our Solution: Sequential enables brands to turn microbiome individuality into evidence-based innovation. Using our global microbiome database of 50,000+ samples covering diverse geographies, ethnicities, life stages and skin states, we provide insight into how different cohorts respond to formulations. We help identify key biological differences between groups and translate these into clear formulation directions. By grounding innovation in measurable variation rather than assumptions, Sequential enables brands to create personalised, microbiome-safe solutions that genuinely meet user needs.  References: Gupta, V., et al. (2017) Geography, Ethnicity or Subsistence-Specific Variations in Human Microbiome Composition and Diversity.   Frontiers in Microbiology.   https://doi.org/10.3389/fmicb.2017.01162 Hwang, B. K., et al. (2021) Effect of the skincare product on facial skin microbial structure and biophysical parameters: A pilot study.   MicrobiologyOpen.   https://doi.org/10.1002/mbo3.1236 Lloyd-Price, J., et al. (2016) The healthy human microbiome.   Genome Medicine.   https://doi.org/10.1186/s13073-016-0307-y Prajapati, S.K., et al. (2025) Microbiome and Postbiotics in Skin Health.   Biomedicines.   https://doi.org/10.3390/biomedicines13040791

  • Not All Toothpaste Works The Same

    Introduction The oral cavity is one of the most structurally diverse environments in the human body, with a unique microbial ecosystem (i.e., microbiome) consisting of bacteria, fungi, viruses and other groups of microorganisms that inhabit and colonise its various physical niches like teeth, gingiva, inner cheeks and saliva (Reynoso-García et al. , 2022). Here, these microbes play a vital role in driving oral health and disease progression, with the majority of bacteria in the oral cavity forming structured microbial biofilms where they carry out functions related to pH regulation, host immune modulation, and nutrient metabolism (Chandra Nayak et al. , 2025).  Some commensal species, like Streptococcus mitis  and Veillonella parvula , are also able to further maintain oral homeostasis by executing antagonistic effects that restrict the growth of periodontopathogens like Porphyromonas gingivalis  and Tannerella forsythia , and cariogenic (decay-causing) species like Streptococcus mutans  (Reynoso-García et al. , 2022; Bloch et al. , 2024). Colonisation by these bacteria can cause inflammatory tissue destruction that drives the progression of periodontal disease, or the production of acids that erode dental enamel and cause dental cavities (Chandra Nayak et al. , 2025). Beyond diet, smoking, and alcohol consumption, one of the key factors that can drive the growth of these pathogens is lack of adherence to proper hygiene practices. Poor oral hygiene habits, such as inadequate brushing and flossing, can increase risk of oral disease progression by promoting biofilm formation and the proliferation of pathogenic species that can disrupt the composition and functioning of the oral microbial community by pushing it towards dysbiosis (Rajasekaran et al. , 2024). Preventative measures to stop this from happening include observation of proper oral hygiene practices and regular use of oral care products like mouthwash, toothpaste, floss string, and interdental brushes to maintain a healthy oral environment that favours the growth of beneficial microbial species over harmful ones (Gallione et al. , 2025). Multiomics (i.e., multiple omics) is an emerging interdisciplinary approach that has permitted a more detailed investigation into the mechanistic mode of action of these oral care products and their overall effect on oral microbial communities. By capturing and integrating data from multiple layers of biological information (e.g., genomics, transcriptomics, proteomics, and metabolomics), multiomics has provided a more comprehensive understanding of product influence over the complex network of interactions underlying these oral microbial communities and host tissues, as well as changes they may induce to the compositional and functional properties of the oral microbiome (Ramji et al. , 2025). This improved mechanistic understanding can be used in future to facilitate the development of more efficacious personal care products and individualised, targeted therapeutics for oral care. Article 1: A randomised, double-blind clinical study into the effect of zinc citrate trihydrate toothpaste on oral plaque microbiome ecology and function (Adams et al.,  2025) This 6-week clinical study aimed to assess the impact of a zinc citrate trihydrate toothpaste (zinc toothpaste) formulation on dental biofilm ecology and function. By using a combined multiomics approach integrating data from metataxonomic, metagenomic, and metatranscriptomic layers, this study looked to provide a detailed analysis of the structural and functional metabolic changes that occur in dental biofilm communities upon exposure to the zinc toothpaste, while also elucidating its mechanism of action and ability to maintain oral hygiene in comparison to a fluoride toothpaste over the course of the study period (Adams et al.,  2025). Results Species-level community analysis of the collected plaque samples revealed significant differences in community composition between users of the zinc toothpaste and users of a fluoride toothpaste after 6-weeks of consistent product use, with significant shifts in composition observed for the zinc toothpaste that were absent in the fluoride group. Furthermore, significant shifts in the relative abundance of 30 taxa were observed for the zinc toothpaste group, while only 8 were observed for the control toothpaste.  In the case of the zinc toothpaste, this included an increase in the abundance of groups like Streptococcus  and Veillonella , core genera associated with a healthy mouth, and a marked decrease in the abundance of Fusobacterium nucleatum subsp. Polymorphum , an opportunistic oral pathogen whose activity has been linked to the maturation of oral biofilm to facilitate the growth of species associated with inflammation and gum disease. Application of the zinc toothpaste also reduced the amount of Porphyromonas pasteri  in the oral cavity, another pathogenic species whose presence has been linked to oral malodour. While the fluoride toothpaste group also displayed changes in some taxa, such as Staphylococcus epidermidis  and Haemophilus haemolyticus , these were far more minimal than the zinc toothpaste, demonstrating the ability of zinc-containing toothpastes to more effectively promote growth of beneficial bacteria at the expense of oral pathogens. Combined metagenomic and metatranscriptomic analyses of these oral microbial communities later found an inhibition of bacterial genes associated with sugar metabolism after zinc toothpaste usage, something that could have implications for reduced production of biofilm metabolites like lactic acid that are damaging to dental enamel. Conversely, an increase in the lysine biosynthesis pathway, a process that has been linked to gum attachment and maintenance, was also observed following use of zinc toothpaste, as well as an increase in nitrogen metabolism and nitrate reduction, which has positive implications for whole-body health, demonstrating the ability of zinc toothpastes to boost genes and metabolic processes associated with good oral health compared to fluoride toothpastes, whose effects on sugar metabolism, lysine biosynthesis, and nitrogen metabolism were far less significant (Adams et al.,  2025). Conclusion This study was able to successfully demonstrate the beneficial effects of using a zinc-containing toothpaste product on the structure and function of the oral microbiome. Use of this toothpaste was shown to be far more effective in modulating oral health than a traditional fluoride one, with significant shifts in both the composition and metabolic activity of these microbial communities being observed after 8-weeks of use. This included triggering an increase in the abundance of beneficial, protective bacteria like Streptococcus and Veillonella , decrease in the abundance of harmful pathobionts like Fusobacterium , as well as suppressing metabolic pathways could push the oral environment in an unhealthy direction to impede disease progression and pathogen colonisation (Adams et al.,  2025).  Strengths and Limitations of Research Strengths Multiomics can also provide a more well-rounded assessment of oral product efficacy during testing by examining their effect on microbiome function in response to product use . This can include elucidating the specific mechanisms by which oral hygiene products or ingredients are able to influence different members of the oral microbiota, while also permitting an improved understanding of significant microbial interactions and their influence over disease modulation and treatment strategies (Adams et al.,  2025; Chandra Nayak et al. , 2025). Limitations The use of dental plaque collection to monitor product effects in many oral multiomics studies can be problematic with regards to the varied composition of bacterial flora at different sites within the oral cavity, and even between surfaces of the same tooth, leading to less precise estimates of community composition at the individual level, and raising issues when tracking compositional shifts over the course of a clinical trial. Collection from predetermined plaque sites can also make it difficult to draw accurate comparisons between healthy and diseased participants, as diseased groups might include samples collected from a mixture of diseased and non-diseased sites (Yama et al. , 2023). Future Directions and Research Microflora imaging approaches may provide information on spatial distribution and microbial activity within the oral microbiota, with techniques such as fluorescence imaging, mass spectrometry, and Raman spectroscopy, enabling direct visualisation of metabolic substrates (e.g., sugars, amino acids, and nucleic acids) and their chemical activity in response to certain oral care ingredients. This can be used to provide an extra layer of depth when evaluating the efficacy of certain oral care products and therapeutics (Lin et al. , 2024). Conclusion Multiomics provides an interdisciplinary approach to studying oral health and the microbiome, with research increasingly focusing on the application of these technologies for the development of oral care ingredients and their effects on the microbiome and host oral environment. Certain products and ingredients that have shown potential as effective agents for oral health modulation include stannous compounds and zinc, with such multiomic approaches further paving the way to better understanding their mode of action, as well as their dynamic interplay with oral biomarkers, with many positive implications for product formulations and oral monitoring. However, much work remains to be done to improve the robustness and accuracy of this field of research. Improving these limitations can pave the way for the development of more effective oral care products and treatments for various oral conditions, product testing, and preventative diagnostic therapeutics. References Adams, S.E. et al.  (2025) ‘A randomised, double-blind clinical study into the effect of zinc citrate trihydrate toothpaste on oral plaque microbiome ecology and function’, Scientific Reports , 15, p. 8136. Available at:   https://doi.org/10.1038/s41598-025-92545-0 . Bloch, S. et al.  (2024) ‘Oral streptococci: modulators of health and disease’, Frontiers in Cellular and Infection Microbiology , 14, p. 1357631. Available at:   https://doi.org/10.3389/fcimb.2024.1357631 . Chandra Nayak, S. et al.  (2025) ‘The Oral Microbiome and Systemic Health: Bridging the Gap Between Dentistry and Medicine’, Cureus , 17(2), p. e78918. Available at:   https://doi.org/10.7759/cureus.78918 . Gallione, C. et al.  (2025) ‘Oral Health Care: A Systematic Review of Clinical Practice Guidelines’, Nursing & Health Sciences , 27(1), p. e70027. Available at:   https://doi.org/10.1111/nhs.70027 . Lin, Y. et al.  (2024) ‘Omics for deciphering oral microecology’, International Journal of Oral Science , 16(1), p. 2. Available at:   https://doi.org/10.1038/s41368-023-00264-x . Rajasekaran, J.J. et al.  (2024) ‘Oral Microbiome: A Review of Its Impact on Oral and Systemic Health’, Microorganisms , 12(9), p. 1797. Available at:   https://doi.org/10.3390/microorganisms12091797 . Ramji, N. et al.  (2025) ‘Multi-Omics Insights into Gingivitis from a Clinical Trial: Understanding the Role of Bacterial and Host Factors’, Microorganisms , 13(10), p. 2371. Available at:   https://doi.org/10.3390/microorganisms13102371 . Reynoso-García, J. et al.  (2022) ‘A complete guide to human microbiomes: Body niches, transmission, development, dysbiosis, and restoration’, Frontiers in Systems Biology , 2. Available at:   https://doi.org/10.3389/fsysb.2022.951403 . Yama, K. et al.  (2023) ‘Dysbiosis of oral microbiome persists after dental treatment-induced remission of periodontal disease and dental caries’, mSystems , 8(5), pp. e00683-23. Available at:   https://doi.org/10.1128/msystems.00683-23 .

  • Your Skin Is Reacting For A Reason

    Skin sensitivity is often treated as a surface level reaction, yet it can reflect a loss of microbial diversity and function. When microbial networks lose complexity and diversity, it can disrupt the production of microbial metabolites that are essential for maintaining skin barrier integrity, and modulating immune responses. This can lead to heightened stinging, redness, and reactivity to products previously tolerated.   What we know: Research has shown that: Reduced microbial diversity limits the production of beneficial metabolites (e.g. short chain fatty acids) that support barrier function, making skin more vulnerable to irritation (Prescott et al, 2017). Loss of microbial balance alters immune signalling pathways, increasing the likelihood of redness, stinging and inflammatory responses (Zhang et al, 2024). Treatments that strip or over-exfoliate the skin can extend irritation cycles, slowing recovery and increasing reactivity over time (Prescott et al, 2017). When microbial recovery is slow, sensitivity persists over time, meaning products that were once tolerated can suddenly trigger discomfort (Mim et al, 2024)   Industry impact and potential: This unlocks a new approach to caring for sensitive skin: Products that help the skin recover and stay balanced, rather than just masking symptoms. Ingredients designed to work gently and gradually, based on how much the skin can tolerate. Cleansers and bases that don’t strip away helpful bacteria, reducing everyday irritation. Clear, evidence-based guidance that supports people with reactive or easily irritated skin.   Our solution: Grounded in robust microbiome science, Sequential enables brands to develop targeted, biologically safe and resilience-focused solutions for sensitive-skin users. With a global microbiome database of over 50,000 samples, we can help you understand how sensitivity varies across different populations, environments and lifestyles. This allows us to guide you in designing formulations that genuinely support diverse skin needs rather than taking a one-size-fits-all approach.   References: Mim, M., et al. (2024). The dynamic relationship between skin microbiomes and personal care products: A comprehensive review. Heliyon, 10. https://doi.org/10.1016/j.heliyon.2024.e34549 . Prescott, S., et al. (2017). The skin microbiome: impact of modern environments on skin ecology, barrier integrity, and systemic immune programming. The World Allergy Organization Journal, 10. https://doi.org/10.1186/s40413-017-0160-5 . Zhang, X., et al. (2024). Microbiome: Role in Inflammatory Skin Diseases. Journal of Inflammation Research, 17, pp. 1057 - 1082. https://doi.org/10.2147/jir.s441100 .

  • The Bright Side of Skincare: How LEDs Influence Microbial Balance

    With LED face masks and light-based skincare rapidly increasing in popularity, light has become a new frontier in skin health. Previously seen as a threat and something that we needed to block or avoid, light is now being seen as therapeutic tool. Yet beyond the visible changes to tone and texture, light also interacts with the skin microbiome. Understanding how different wavelengths influence this ecosystem is key to ensuring that light enhances, rather than harms, our skin’s microbial balance. What we know: Each wavelength of light interacts differently with both skin cells and the microbes that live on them. Of the wavelengths, red and blue have been found to have the best therapeutic benefits. Blue light (400–470 nm) has been shown to target bacteria like Cutibacterium acnes and Staphylococcus aureus , species commonly linked to acne and inflammation. By interacting with microbial chromophores, it produces reactive oxygen species that damage bacterial membranes. This can help rebalance the microbiome when used at the right dose (Plattfaut et al., 2021). Red light (620–750 nm), has been shown to have anti-inflammatory and tissue-repair properties. It’s widely used in photobiomodulation therapy and research suggests that red light can enhance wound healing and reduce bacterial load when paired with blue light (Lee  et al , 2007). Together, these wavelengths demonstrate that light can influence microbial composition and function, not just skin appearance. But precision matters: the wrong dose or wavelength could just as easily disrupt the skin microbiome. Industry Impact and Potential As light-based therapies and tools move from specialist clinic to home use, understanding their microbiome impact becomes essential. The skin microbiome is now a critical factor in dermatological science and, consumer skincare innovation must consider the impact in respect to the microbiome. Emerging research hints at the potential of personalised phototherapy tuned to an individual’s microbiome composition. Microbiome-safe LED protocols that support healthy microbial diversity. Combinations of blue and red light that offer both microbial control and skin repair. These developments can help us redefine how we think about light, as a precision tool for microbial balance. Our solution: Sequential is at the forefront of microbiome product testing and development, providing tailored solutions to understand how environmental factors, such as light, influence the skin microbiome. Using advanced research techniques and supported with a database o f over 50,000 human samples, Sequential offers comprehensive services to evaluate product impacts and formulations on the skin microbiome.   Our goal is to provide science-driven insights that help brands design light-based treatments and formulations that work with the microbiome, not against it. References: Lee, S., You, C., & Park, M., 2007. Blue and red light combination LED phototherapy for acne vulgaris in patients with skin phototype IV.  Lasers in Surgery and Medicine , 39. https://doi.org/10.1002/LSM.20412 . Plattfaut, I., Demir, E., Fuchs, P., Schiefer, J., Stürmer, E., Brüning, A., & Opländer, C., 2021. Characterization of Blue Light Treatment for Infected Wounds: Antibacterial Efficacy of 420, 455, and 480 nm Light-Emitting Diode Arrays Against Common Skin Pathogens Versus Blue Light- Induced Skin Cell Toxicity.  Photobiomodulation, photomedicine, and laser surgery , 39 5, pp. 339-348.

  • How Pregnancy and Postpartum Transform the Skin Microbiome

    During pregnancy, the skin microbiome undergoes significant shifts.  Across the trimesters, both the composition and behaviour of skin bacteria change. Postpartum, the maternal skin microbiome continues to evolve which is influenced by hormonal resets, environmental exposures, and hygiene practices. These shifts can also influence an infant’s earliest microbial encounters, during a critical period of skin development. What We Know: Pregnancy significantly changes the skin microbiota with key bacteria diminishing in the first trimester (Radocchia et al,  2024).  Progressing through the trimesters, the microbiome becomes simpler as highly connected species decline, reducing microbial resilience (Mesa et al, 2020). This impacts the skin’s barrier function, making the skin more susceptible to dryness, irritation, and inflammation (Radocchia et al,  2024). Maternal microbiome changes during pregnancy and postpartum can influence infant skin health and early dermatological risk (Mutic et al,  2017).   Industry Impact and Potential Pregnancy and postpartum present an innovative opportunity for microbiome-focused skincare. Barrier-focused care for sensitive and reactive skin: As microbial networks decline in complexity, barrier function becomes more vulnerable. pH-balanced systems, ceramides, and gentle formulations can help maintain stability. Probiotic and prebiotic skincare: Targeted probiotic or prebiotic formulations can help restore microbial diversity, reduce inflammation, and strengthen skin resilience. Education and transparency:  Clear labelling (e.g., “microbiome-safe,” “pregnancy-safe”) and guidance on supportive vs. avoidable ingredients empower informed decision-making. Our Solution At Sequential, we connect advanced microbiome science with real-world product innovation to support maternal skin health during pregnancy and postpartum. We apply advanced microbiome profiling and multi-omic analysis to help brands understand how pregnancy and postpartum affect skin microbial balance. With a global database of 50,000+ samples and customised testing platforms, we assess whether formulations are microbiome-safe, gentle for pregnancy, and supportive of beneficial bacteria. Through targeted studies and formulation guidance, we enable science-backed products that protect maternal skin. References : Mesa, M. et al. (2020). The Evolving Microbiome from Pregnancy to Early Infancy: A Comprehensive Review. Nutrients, 12.  https://doi.org/10.3390/nu12010133 Mutic, A. et al. (2017). The Postpartum Maternal and Newborn Microbiomes.  MCN: The American Journal of Maternal/Child Nursing, 42, 326–331. https://doi.org/10.1097/nmc.0000000000000374 Radocchia, G. et al. (2024). Women Skin Microbiota Modifications during Pregnancy.  Microorganisms, 12(4), 808. https://doi.org/10.3390/microorganisms12040808

  • Understanding the Microbial Roots of Seborrheic Dermatitis

    Seborrheic dermatitis (SD) is a common inflammatory skin condition primarily affecting the scalp, face and chest. It appears as red, flaky, greasy patches or plaques and can cause itching and discomfort. It is a non-contagious condition varying in severity, from mild dandruff to persistent inflamed lesions. What we know: SD is linked to three main factors: increased sebum (oil) production, colonization by Malassezia  yeast, and an abnormal immune response. Genetics, skin barrier dysfunction, environmental triggers and stress also contribute to this condition (Adalsteinsson et al,  2020). Malassezia species, especially M.restricta  and M. globosa , are abundant in SD. These yeasts hydrolyse skin lipids, producing irritating fatty acids that drive inflammation (Tao et al , 2021). SD skin shows increased transepidermal water loss, reduced ceramides, and altered lipid composition, increasing irritation and microbial imbalance (Wikramanayake et al , 2019). Research highlights SD occurs across all skin types with treatment needs with preferred treatments varying across the population (Polaskey et al , 2024).   Industry impact and potential As insights into SD evolve, the industry has a unique chance to create smarter and more inclusive solutions. Microbiome-targeted products: Products that help regulate microbial balance, particularly, may help reduce flare-ups while preserving beneficial species. Barrier-supportive solutions: Lipids, ceramides, and pH-balanced systems can strengthen and enhance barrier resilience, addressing underlying weakness. Inclusive and culturally sensitive solutions: Treatments designed and tested across all skin tones and hair textures can ensure effectiveness across diverse users. Simplified treatment routines: Streamlined regimes can help to address consumer frustration with persistent symptoms and complex, time-consuming treatment. Our solution At Sequential, we support the development of next-generation seborrheic dermatitis solutions through deep microbiome profiling and multi-omic analysis. With a global database of 50,000+ samples, we help brands understand how Malassezia, bacterial communities, and barrier function interact across different skin and scalp types. We assess whether formulations rebalance the microbiome, strengthen the barrier, and target inflammation-related biomarkers, enabling the creation of microbiome-safe, inclusive, and effective products. Grounded in robust microbiome science, Sequential empowers brands to deliver targeted and culturally sensitive solutions for seborrheic dermatitis.   References: Adalsteinsson, J. et al. (2020)  Experimental Dermatology . https://doi.org/10.1111/exd.14091 Polaskey, M. et al. (2024)  JAMA Dermatology . https://doi.org/10.1001/jamadermatol.2024.1987 Tao, R. et al. (2021)  Experimental Dermatology . https://doi.org/10.1111/exd.14450 Wikramanayake, T. et al. (2019)  Experimental Dermatology . https://doi.org/10.1111/exd.140 06

  • Protein Isn’t Just For Gym Gains, Your Skin Depends On It Too

    Protein may be best known for building muscle, but in skincare, it plays an equally vital role. From the nutrients we eat to the peptides in formulations, protein helps power the strength, and resilience of our skin, showing that real skin health starts from both inside and out.   What we know: Despite its reputation as a nutritional staple, protein plays a foundational role in skin biology and microbiome health. Research shows that: Collagen, elastin, and keratin form the skin’s structural framework, influencing elasticity, firmness, and barrier integrity. When these proteins degrade, skin becomes more fragile and slower to repair (Solano, 2020). Antimicrobial peptides (AMPs) both inhibit harmful microbes and maintain a balanced microbiome, vital for barrier function (Rademacher et al, 2021). Peptides influence the composition of the wound microbiome, promoting beneficial bacteria and suppressing harmful species, which further accelerates healing (Adnan et al, 2025). Industry impact and solution: The expanding understanding of protein’s role in skin and microbial health presents exciting opportunities for targeted innovation. Peptide-driven repair systems: Bioactive peptides support collagen synthesis, accelerate healing, and reinforce the skin barrier, offering targeted solutions for fragile or compromised skin. This immediate potential is matched by a crucial need for deeper scientific understanding, particularly when considering: Long-term research and safety innovation: The lasting effects of continuous peptide or protein exposure on the skin microbiome remain unclear, with most studies focusing on short-term outcomes like wound healing and immediate microbial shifts.   Our solution: At Sequential, we help brands innovate confidently with protein- and peptide-based formulations. Using our science-driven microbiome testing and a database of 50,000+ samples, 4,000 ingredients, and 10,000+ global participants, we provide clear insights into how peptides and proteins influence the skin and its microbiome. Our customisable studies replicate real-world conditions to assess safety, efficacy, and long-term microbiome impact—supported by expert formulation guidance References : Adnan, S. et al. (2025). Antimicrobial peptides in wound healing and skin regeneration. Int. J. Mol. Sci., 26.   https://doi.org/10.3390/ijms26135920 Rademacher, F., Gläser, R. & Harder, J. (2021). Antimicrobial peptides and proteins: Interaction with the skin microbiota. Exp. Dermatol., 30, 1496–1508.   https://doi.org/10.1111/exd.14433 Solano, F. (2020). Metabolism and functions of amino acids in the skin. Adv. Exp. Med. Biol., 1265, 187–199.   https://doi.org/10.1007/978-3-030-45328-2_11

  • Human-based testing is the way forward for product validation

    Introduction In the personal care industry, developing products that target or affect the skin, scalp, vaginal, and oral microbiome requires robust scientific validation that meets both biological and regulatory standards. While in vitro  (laboratory) testing provides valuable preliminary data, they cannot fully replicate the complex interactions occurring in the human body. Clinical testing in human subjects on the other hand captures the dynamic interactions between microbial communities and the host in their natural environment. Increasingly, multi-omic approaches, which combine genomic, transcriptomic, proteomic, and metabolomic data, are being used in these human studies to deliver a far more comprehensive understanding of how products influence both microbes and host biology simultaneously. Complexity of the Human Skin Human skin is a highly complex, multi-layered organ whose structure is essential for both barrier function and supporting a balanced microbiome. The epidermis, dermis, and hypodermis create distinct microenvironments with varying oxygen levels, nutrients, and physicochemical properties, while specialized structures, such as, hair follicles, sebaceous and sweat glands, and apocrine glands, provide unique habitats that shape microbial communities (Kolarsick et al ., 2011). Host-microbe interactions are dynamic, with keratinocytes and immune cells continuously communicating with microbes to maintain equilibrium. This means that product effects cannot be separated from host responses, because microbial behavior depends on this three-dimensional architecture. Simplified in vitro systems often fail to predict real-world outcomes.  To further complicate this interaction, skin biology and the microbiome influence each other at multiple molecular layers. Multi-omic analysis enables researchers to capture these layered responses by examining not only changes in microbial composition, but also shifts in gene expression, protein activity, and metabolite production in both the host and the microbiome. This depth of information is only achievable in vivo , where the full biological context, and environmental exposure remains intact. Understanding in vitro  testing  In vitro  testing involves experiments conducted in controlled laboratory environments. Common methods include, Co-culture systems: Culturing multiple microbial species together to study a product's impact on interspecies interactions and community dynamics (Rose et al ., 2024). However this comes with several limitations including, the inability to include the complete microbial ecosystem, as it is difficult to control the ratios between bacterial strains (Shishkov et al ., 2024). Another limitation is that standard liquid media do not accurately mimic the structured, biofilm-rich environment of the skin. Non-adherent bacteria can be lost during media changes, and competitive dynamics among strains can lead to overgrowth of certain species, reducing the physiological relevance of the model (Shishkov et al ., 2024). 2D and Scaffold-Based 3D Skin Models: 2D skin models consist of keratinocytes grown as monolayers, sometimes co-cultured with fibroblasts, and are widely used for rapid, inexpensive screening of cytotoxicity, cellular uptake, and basic responses to ingredients, however, they lack the 3D architecture and barrier function of real skin. Scaffold-based 3D skin models, such as reconstructed human epidermis (RHE) and full-thickness human skin equivalents (FTHSE), use natural, synthetic, or decellularized scaffolds to mimic the extracellular matrix and support multilayered cell growth, differentiation, and fibroblast-keratinocyte interactions. These models better replicate the stratum corneum, barrier function, and cellular crosstalk, allowing testing of product effects on toxicity, irritation, penetration, and even disease-like conditions, nonetheless, they still lack appendages, full vascularization, and all native cell populations, limiting their ability to fully predict skin responses, particularly for microbiome interactions (Galvan, Pellicciari & Calderan, 2024). While these methods offer controlled conditions for initial screening, and are continuously evolving, they cannot still replicate the complex microenvironment of human tissues that personal care products actually encounter during use. Limitations of in vitro  testing While 3D skin models improve physiological relevance compared with 2D cultures, they still have important limitations for studying the human skin microbiome. Most models lack skin appendages such as hair follicles and sebaceous glands, making it difficult to culture anaerobic bacteria like Cutibacterium  or maintain a complete microbial community. Simple synthetic membranes or 2D models cannot support symbiotic host-microbe interactions and are limited to very short-term experiments. Even simplified 3D models that recreate only the stratum corneum can maintain microbial populations for about a week but do not replicate the full tissue complexity needed for barrier function or product testing (Galvan, Pellicciari & Calderan, 2024). Additionally, environmental factors such as moisture, pH, sebum production, and exposure to cosmetic or hygiene products vary widely among individuals and are challenging to model in vitro . So while in vitro  testing is essential for initial screening and mechanistic studies, its predictive value for real-world human outcomes is limited.  What do the regulatory bodies say According to the Cosmetic Supervision and Administration Regulation (CSAR) and the Standards for Cosmetic Efficacy Claim Evaluation, “claims of cosmetics need to be supported by scientific evidence”, and in vitro  data alone may no longer be sufficient for substantiating personal care product claims (Ferreira et al ., 2022).  Similarly, the UK Advertising Standards Authority (ASA) acknowledges that while in vitro proof-of-concept studies are valuable in research, they should generally be supported by relevant human data, ideally reflecting the target population (CAP News, 2021). For “new” or “breakthrough” objective claims, the ASA and the Committee of Advertising Practice (CAP) require more stringent evidence, typically including at least one well-controlled experimental human study, often complemented by observational data (AdviceOnline, 2025). Consistent with these standards, QVC also mandates that all product claims regarding safety and efficacy, whether made on-air or off-air, must be substantiated with adequate documentation, which may include third-party clinical testing where appropriate (Quality Assurance Overview, 2018). Together these regulatory bodies highlight a clear expectation across markets, that claims must be grounded with credible, scientifically validated evidence. Through robust human studies and transparent documentation, brands are expected to demonstrate that their products perform safely and effectively as advertised. Understanding Clinical testing Clinical testing for personal care products involves evaluating formulations directly on human volunteers under conditions that simulate real-world use. Standard methodologies include, Randomized Controlled Trials (RCTs): Gold-standard studies where participants are randomly assigned to treatment or control groups to minimize bias (Braga et al ., 2024). Skin Sampling Techniques: Methods such as skin swabs, tape strips, and punch biopsies are employed to collect microbial samples from various skin sites (Santiago-Rodriguez et al ., 2023).  Microbiome Analysis: 16S rRNA gene sequencing, whole-genome shotgun metagenomics, and transcriptomic profiling to characterize microbial community changes (Santiago-Rodriguez et al ., 2023). Biophysical Measurements: Non-invasive instrumentation to assess skin barrier function, hydration, sebum production, pH, and desquamation (Hwang et al ., 2021). Perception Questionnaires: Standardized questionnaires capturing subjective experiences of relief, comfort, and product acceptability. They bridge the gap between biological data and user perception, ensuring that the observed microbial or biophysical data translate into meaningful benefits for consumers. Clinical testing in humans captures the dynamic interactions between microbial communities and the host in their natural environment. By studying human participants, researchers can assess the full diversity of microbiomes that are absent in artificial culture systems. Moreover, clinical testing supports the development of personalized treatments by accounting for inter-individual variability in microbial composition, genetics, and lifestyle factors, which can significantly influence outcomes. Without clinical testing, laboratory findings, even those that appear promising  in vitro , may fail to translate into real benefits for patients or consumers.  In vitro models provide mechanistic understanding and cost-effective early screening, however, only well-designed clinical trials can deliver the comprehensive evidence necessary to substantiate product claims, ensure consumer safety, and demonstrate meaningful benefits reflective of the complex interactions in living humans.  Moreover, human skin exhibits remarkable diversity across ethnicities, ages, genders, and body sites. Clinical testing captures this variability by enrolling participants representative of the target population, providing insights into how products perform across different skin types and conditions. This population-level understanding is essential for developing inclusive products that deliver consistent benefits to diverse consumer groups.  Furthermore, clinical testing provides the foundation for consumer confidence and commercial success. Products supported by robust clinical evidence convey scientific credibility and a commitment to consumer well-being, setting them apart in an increasingly competitive marketplace. As consumers become more informed about skincare and microbiome science, there is a growing expectation for transparency and data-driven validation. Incorporating multi-omic analysis into clinical studies strengthens this further by demonstrating not only visible outcomes but also the underlying biological mechanisms, offering a deeper level of scientific clarity that resonates with both regulators and consumers. Therefore, it is essential that products are substantiated by rigorous scientific research and evaluated on real human skin to ensure both efficacy and trustworthiness. About Sequential Sequential helps simplify the entire process of generating strong scientific evidence for personal care products, by handling recruitment, sampling, analysis, and data reporting in one place, so that it runs faster and smoother. Our clinical testing approach shows how products perform in real-world conditions, across skin, scalp, vaginal, and oral sites, so brands can make confident decisions backed by high-quality microbial and molecular data (multi-omics).  A proprietary non-invasive sampling method ensures consistent, rich biological material with minimal irritation for participants, supporting smoother studies and stronger datasets. Each study is tailored to match the intended consumer population, supported by biophysical measurements and perception data to capture both measurable effects and user experience. This provides a complete dataset that demonstrates efficacy, and strengthens claim substantiation. All data and results are presented in clear, detailed, easy-to-interpret reports, making it simple for anyone to understand the science, and translate the insights directly into formulation improvements, claims, and product strategy. By handling all these processes under one roof, Sequential reduces complexity, shortens timelines, and provides brands with clear, actionable insights, making it easier to deliver products that are credible, effective, and trusted. References  AdviceOnline, 2025 June 23; Substantiation for health, beauty, and slimming claims. https://www.asa.org.uk/advice-online/substantiation-for-health-beauty-and-slimming-claims.html Braga LH, Farrokhyar F, Dönmez Mİ, Nelson CP, Haid B, Herbst K, Garriboli M, Cascio S, Nieuwhof-Leppink A, Kaefer M, Bägli DJ, Kalfa N, Ching C, Fossum M, Harper L. Randomized controlled trials - The what, when, how and why. J Pediatr Urol. 2025 Apr;21(2):397-404. doi: 10.1016/j.jpurol.2024.11.021. Epub 2024 Dec 3. PMID: 39701869. CAP News, 2021 Jan 28; Skin in the game - an update on microbiome claims for cosmetics. https://www.asa.org.uk/news/skin-in-the-game-an-update-on-microbiome-claims-for-cosmetics.html Ferreira M, Matos A, Couras A, Marto J, Ribeiro H. Overview of Cosmetic Regulatory Frameworks around the World. Cosmetics . 2022; 9(4):72. https://doi.org/10.3390/cosmetics9040072 Galvan A, Pellicciari C, Calderan L. Recreating Human Skin In Vitro: Should the Microbiota Be Taken into Account? Int J Mol Sci. 2024 Jan 18;25(2):1165. doi: 10.3390/ijms25021165. PMID: 38256238; PMCID: PMC10816982. Hwang BK, Lee S, Myoung J, Hwang SJ, Lim JM, Jeong ET, Park SG, Youn SH. Effect of the skincare product on facial skin microbial structure and biophysical parameters: A pilot study. Microbiologyopen. 2021 Oct;10(5):e1236. doi: 10.1002/mbo3.1236. PMID: 34713611; PMCID: PMC8494714. Kolarsick, Paul A. J. BS; Kolarsick, Maria Ann MSN, ARHP-C; Goodwin, Carolyn APRN-BC, FNP. Anatomy and Physiology of the Skin. Journal of the Dermatology Nurses' Association 3(4):p 203-213, July 2011. | DOI: 10.1097/JDN.0b013e3182274a98 Quality Assurance Overview, 2018 July. https://www.qvcuk.com/content/dam/qvc_uk/pdf/vendor-relations/QVC%20UK%20Beauty%20Overview.pdf?srsltid=AfmBOor499tO1ighEImeZfonX-1M6ohWHkfnKQh_RC7k1buX5A91mI3- Roso, A., Pecastaings, S., Cambos, S., Martin, R., Bauchet, L., Roubinet, B., ... & Garcia, C. (2024). An Innovative Model Based on Wild Type Bacteria Co-Culture to Identify Cosmetic Ingredients That Respect the Skin Microbiota. Journal of Cosmetic Science , 75 (6). Santiago-Rodriguez TM, Le François B, Macklaim JM, Doukhanine E, Hollister EB. The Skin Microbiome: Current Techniques, Challenges, and Future Directions. Microorganisms. 2023 May 6;11(5):1222. doi: 10.3390/microorganisms11051222. PMID: 37317196; PMCID: PMC10223452. Shishkov, Vsevolod & Bikmulina, Polina & Kardosh, Anna & Tsibulnikov, Sergey & Grekova, Ekaterina & Kolesova, Yulia & Zakharova, Polina & Nesterova, Anastasiia & Pereira, Frederico & Kotova, Svetlana & Olisova, Olga & Vosough, Massoud & Shpichka, Anastasia & Timashev, Peter. (2024). Advancing the in vitro drug screening models: Microbiome as a component of tissue-engineered skin. Bioprinting. 45. e00379. 10.1016/j.bprint.2024.e00379.

  • Why Your Lips Need Special Care

    The lips may be a small part of the face, but biologically, they behave in entirely unique ways. As temperatures drop and humidity shifts, your lips feel the change immediately; a reminder of how delicate they are and how much care they truly need. What we know Despite their importance, lips remain one of the least researched skin sites, especially regarding the microbiome. Current scientific knowledge highlights that: Lip skin has significantly higher transepidermal water loss (TEWL) and lower water content compared to other facial regions, such as the cheeks. (Kim et al, 2021). Lip skin is less equipped to defend against external stressors due to having no oil glands and a thin stratum corneum.  (Lee et al, 2022). The structural differences make the lip microbiome highly responsive and more easily disrupted by environmental impactors including cold weather, UV exposure, and airflow. These contribute to irritation, chapping, and inflammation (Gfeller et al, 2019). Industry Impact and Potential The unique biology of lip skin creates both a challenge and an opportunity for product innovation. Potential areas of innovation include: Advanced moisturizing systems: Next-generation blends of oils, waxes, and occlusives that work together to reduce water loss, restore suppleness, and reinforce the lip barrier. Barrier and anti-inflammatory formulations: Formulations including ceramides and panthenol can help stabilise barrier function, calm irritation, and support recovery from environmental stressors.   Age related support: Gentle, microbiome-supportive formulations that address thinning, dryness, and fine lines offer a growing opportunity for targeted, non-irritating lip renewal. Our Solution At Sequential, our customisable services can help brands formulate products that are effective for looking after lips with our extensive microbiome testing. With a database of over 50,000 microbiome samples, 4,000 ingredients, and 10,000+ testing participants, we provide the scientific clarity needed to develop high-performing, microbiome-supportive lip care. Winter may be tough on lips, but with the right science, solutions can be both protective and powerful.   References : Gfeller, C. et al. (2019). Novel lip cream protecting against triggers of recurrent herpes labialis. Clin. Cosmet. Investig. Dermatol. , 12, 193–208.   https://doi.org/10.2147/ccid.s179430 Kim, J. et al. (2021). Relationship between lip skin characteristics and corneocyte unevenness ratio in assessing lip scaling. Int. J. Cosmetic Sci. , 43, 275–282.   https://doi.org/10.1111/ics.12692 Lee, H. & Kim, M. (2022). Skin barrier function and the microbiome. Int. J. Mol. Sci. , 23.   https://doi.org/10.3390/ijms232113071

  • Multi-Omics and Personal Care

    Introduction Multiomics (i.e., multiple omics; hereafter referred to as omics) is an emerging interdisciplinary approach to studying complex systems that involves integration of biological data from multiple "omics" fields. Typically including a combination (or all) of the following: genomics, epigenomics, transcriptomics, metabolomics, and proteomics. This provides a comprehensive understanding of how these systems operate at multiple scales from the molecular to whole-organism level, including the study of individual hosts and their associated microbial communities (Ning and Li, 2023).  While current approaches to microbiome data analysis mostly involve shotgun metagenomic or 16S rRNA amplicon sequencing, which can provide detailed information on the compositional diversity of these host-associated communities, they fail to provide much depth on their functional role or the complex network of interactions by which they communicate with the host (Chetty and Blekhman, 2024). Omics approaches are able to provide a much more holistic model of these traits by capturing and integrating these multiple omics layers to give a better understanding of the mechanisms underlying these host-microbe interactions, as well as their influence on host health and physiology (Chetty and Blekhman, 2024). This makes them an incredibly ideal technology for use in characterising host microbiomes by providing a comprehensive analysis of these complex systems and their dynamic interplay. Some examples of the types of omics data can be obtained on these host-microbe systems for integrative omics analysis can be viewed in the table below: Such approaches are increasingly being implemented in the context of product development for skin care, where they can provide a holistic perspective on the overall impact of personal care products on both skin health and the microbiome, as well as assessing the interplay between the two. Study 1: Multi-omics analysis to evaluate the effects of solar exposure and a broad-spectrum SPF50+ sunscreen on markers of skin barrier function in a skin ecosystem model (Jacques et al. , 2025) Using an original reconstructed human epidermis (RHE) model colonised with human microbiota and supplemented with human sebum, this study aimed to analyse the effects of simulated solar radiation (SSR) on skin metabolites and lipids. It also assessed the effectiveness of an ultraviolet/blue light (UV/BL) broad-spectrum sunscreen with a high sun protection factor (SPF50+) in protecting the skin using skin biomarkers. This was a follow-up to a previous study conducted by the same authors looking at the effects of SSR on the skin microbiome (Jacques et al. , 2025). Results Comparative metabolomic analyses of the RHE skin model post-irradiation revealed changes in the levels of several natural moisturising factors (NMFs). This included a reduction in the relative amounts of alanine, N-acetyl putrescin, histidine, and glutamine 24 hours after exposure, while lactate, ornithine, trans-UCA and PCA (both on the skin surface and in the epidermis) were found to be higher. The decrease in some of these NMFs could promote skin dehydration following irradiation. Furthermore, the increased abundance of filaggrin byproducts like UCA and PCA may be attributed to the enhanced breakdown of filaggrin (a skin structural protein) upon SSR radiation, with the degradation of this protein contributing to impairment of the physical and biochemical barrier functions of the stratum corneum. Glycerophospholipid metabolism was also affected following SSR exposure in this RHE model, with an increase in the levels of glycerol and reduction in epidermal choline, glycerophosphocholine and phosphorylcholine observed in the treatment group. Such an increase in glycerol could be linked to either enhanced glycerophosphocholine degradation or an impairment in the glycerophospholipid biosynthesis pathway, and may be secreted in response to skin irradiation following irradiation as a way to maintain skin health owing to its hygroscopic nature. Although, this benefit may be offset by the simultaneous decrease in epidermal choline, which may disrupt skin barrier function and promote skin dehydration. Lipidomic analysis found a lower level of free fatty acids (FFAs) in the RHE following SSR exposure, which could be the result of SSR-induced inhibition of enzymes involved in lipid synthesis pathways. These changes may result in an imbalance in skin lipid composition that destabilises skin barrier organisation and integrity. Elevated levels of skin cholesterol were also observed following treatment, where it may work to activate inflammatory pathways associated with sun exposure and cause skin barrier disruption. Furthermore, SSR-exposure was shown to disrupt ceramide biosynthesis and composition in the skin in a manner that might trigger inflammation and disrupt skin barrier function. Following these omics analyses, the group then assessed the effectiveness of a broad-spectrum SPF50+ sunscreen in preventing SSR-induced changes to the skin. They found application of this broad-spectrum SPF50+ sunscreen was able to prevent many of the previously observed changes to NMF, metabolite and ceramide levels following SSR exposure in the RHE model, allowing it to protect the skin and its components against irradiation-induced disruption and consequences like dehydration, inflammation and damage (Jacques et al. , 2025). Conclusion Using a reconstructed skin ecosystem model, this study was able to provide information on the impact of single-dose SSR on the skin metabolome and lipidome, with effects observed in the levels of various skin components like natural moisturising factors, metabolites, and lipids that are predicted to cause irradiation-associated effects such as dehydration, reduced barrier function, and inflammation. They also used similar omics approaches to validate the effectiveness of an innovative UV/BL broad-spectrum SPF50+ sunscreen in preventing these SSR-induced changes to skin components levels, as well as predicting how this might mitigate against any associated negative physical effects (Jacques et al. , 2025). Study 2: Multi-omics approach to understand the impact of sun exposure on an in vitro skin ecosystem and evaluate a new broad-spectrum sunscreen (Jacques et al. , 2024) Using an original reconstructed human epidermis (RHE) model colonised with human microbiota and supplemented with human sebum, this precursor study aimed to analyse the effects of simulated solar radiation (SSR) on skin metabolites and microbiome composition as a way to understand the underlying interactions between the skin and its associated microbiota. It also assessed the effect of a broad-spectrum sunscreen on skin ecosystem metabolites and pathways during SSR exposure (Jacques et al. , 2024). Results Analysis of the skin metabolome following SSR exposure revealed a change in the composition of the whole RHE metabolome, with 51 significantly altered metabolites identified. These included molecules such as uric acid, glutamine/glutamate, and L-pyroglutamic acid/5-oxoproline, which are predicted to play a role in inducing generation of reactive oxygen species (ROS) and oxidative stress pathways in the skin. Lactate production was also elevated following exposure, which can result in skin acidosis to suppress immune function. Furthermore, three distinct metabolic pathways (glycerophospholipid, starch and sucrose, and tetrahydrobiopterin pathways) were also found be significantly affected post-SSR exposure, with the latter possibly having some involvement in mediating host-microbiome interactions following SSR-exposure.  Compositional microbiome analysis was then used to examine the crosstalk between skin components and cutaneous communities following SSR exposure. Following irradiation treatment, Burkholderia and Cutibacterium  became significantly enriched in the skin microbiota, with the latter genus possibly influencing tyrosine metabolism both in and on the surface of the skin via propionate production, a major Cutibacterium  metabolites known to inhibit UVB-induced melanogenesis by inhibiting cellular tyrosinase activity. Further analysis of the skin mycobiome found a reduced abundance of the genus Malassezia , with such a depletion likely influencing the composition of skin metabolites like tryptophan and indole. The lipophilic nature of these yeasts mean they are normally able to convert this tryptophan into indole compounds for immune activation, however, under such conditions their metabolisms might be altered in a way that differentially modules the host immune system and prioritises synthesis of melanin and photoprotective indolic compounds. Like the previous study, after conducting these -omics analyses, the group then assessed the effectiveness of a broad-spectrum SPF50+ sunscreen in preventing SSR-induced changes to the skin and its microbiome. Once again they found application of this broad-spectrum SPF50+ sunscreen to prevent many of the previously observed changes to metabolite and microbiome profiles following SSR exposure in the RHE model, further demonstrating its ability to buffer irradiation-induced disruption and consequences like dysbiosis or inflammation (Jacques et al. , 2024). Conclusion This study is the first to explore the underlying mechanisms of sun exposure on skin host–microbiota interactions and their biological consequences using an in vitro model to represent the skin ecosystem (skin surface lipids and microbiota) and an integrated omics approach combining metabolomic and microbiomic data. Doing so allowed for accurate characterisation of the skin’s metabolomic signature following irradiation-exposure, with changes in the metabolite profile associated with reactive oxygen species (ROS) generation, inflammation and oxidative stress pathways in the skin being observed. They also explored how interactions between the skin and cutaneous microbiota can be influenced under such conditions, including reduced microbial diversity and possible altered function. The SPF50+ sunscreen was also shown to protect against the negative effects of SSR exposure, including disruption to host–microbial interactions and microbial diversity (Jacques et al. , 2024). Study 3: Multi-omic approach to decipher the impact of skincare products with pre/postbiotics on skin microbiome and metabolome (Li et al. , 2023) This clinical study aimed to decipher the impact of pre- and postbiotic skincare products using an integrated omics approach involving 16S rRNA gene sequencing, shotgun metagenomics and untargeted mass spectrometry-based metabolomics to explore the mechanism-of-action of a triple-biotic complex containing a combination of a prebiotic (inulin), a “smart biotic” (butyloctanol) and postbiotics (lactic acid and pyruvic acid) on skin health through modulation of the skin microbiome and metabolome over a 6-week treatment course (Li et al. , 2023). Results The researchers found application of the triple-biotic treatment significantly reduced the abundance of opportunistic pathogens, such as Pseudomonas stutzeri and Sphingomonas anadarae , while also increasing the amount of commensals like Halomonas desiderata  and Streptococcus mitis  that are positively correlated with skin hydration. Further microbiome metagenomic analysis revealed enrichment of bacterial sugar degradation pathways in the prebiotic treatment group compared with baseline controls. This could serve to generate more lactic acid through active degradation of the inulin prebiotic, promoting skin hydration and maintaining its pH. Metabolomic analysis revealed enrichment of several clinically relevant metabolites in the prebiotic group, such as long-chain/medium-chain fatty acids, Fatty acid esters, Fatty Acyls, Dicarboxylic acids and derivatives that are known to have positive effects on skin health. For example, fatty acids and esters, and fatty acyls contribute to skin barrier functions, while dicarboxylic acids have antimicrobial and anti-inflammatory properties. Correlation analysis between microbiome and discriminant clinically relevant metabolites revealed a negative correlation between the reduction of S. anadarae and P. stutzeri  with fatty acids and dicarboxylic acids, while the increase of H. desiderata  was positively correlated to certain metabolites associated with the increase of skin hydration (Li et al. , 2023). Conclusion This study demonstrated a significant positive effect of a triple-biotic complex consisting of a prebiotic, biotic, and postbiotic on the physical and microbial parameters of skin following 6-weeks of topical application, with enhanced skin hydration and a more favourable shift in microbiome composition towards favourable commensals and away for opportunistic pathogens. Some of these commensal species were also found to positively correlate with skin hydration following analysis of the microbiome metagenome and metabolome, presenting potential bacterial targets for the development of future therapeutics (Li et al. , 2023). Strengths and Limitations of Research (integrated omics to skincare) Strengths: The implementation of such integrated omics approaches examining data from various omics datasets has allowed for the successful identification of clinically relevant strains and metabolites of interest that could act as targets for the development of future personal care products addressing a diverse set of issues surrounding skin health, for example, by enriching topical formulations with the desired microbial strains and their metabolites (Li et al. , 2023). Omics can also provide a holistic assessment of product efficacy during testing by accurately modelling how different environmental conditions can affect product performance on a range of parameters such as skin physiology and components by examining the molecular cross-talk that occurs between the three, as well as elucidating the specific mechanism of action by which it is able to do so (Jacques et al. , 2025). The combined analysis of multiple streams of omics data also open up avenues to better understand host-microbiome interactions by linking host physiology to microbiome function, allowing for a more comprehensive analysis of how this dynamic relationship can be altered in response to intrinsic and extrinsic factors, as well as how these interactions can change (or be maintained) by personal product use. This information can be used to improve formulations so that they avoid pushing the microbiome towards unfavourable dysbiosis, or promote a more balanced microbiome in the case of treating dysbiotic disorders (Jacques et al. , 2024). Limitations: Many existing omics studies rely on the use of in vitro  models to gather data on skin physiology and product performance, making it difficult to fully reproduce the complex interplay that exists between host metabolism and the cutaneous microbiota in such a static system (Jacques et al. , 2024). While many omics studies have succeeded in promoting a deeper understanding of host-microbiome interactions, there is still a lacking standardised approach for the integration of these multiomics layers, which can make it difficult to both draw accurate comparisons between studies, and determine whether observations are real or pipeline-related artifacts (Chetty and Blekhman, 2024). Many of the computational tools and bioinformatics infrastructure currently available are significantly limited in their ability to support analysis, integration, and interpretation of these large omics datasets, making it difficult to obtain meaningful insights from the data. Those tools that are able to support these processes are usually inaccessible to smaller research groups and labs owing to cost, further restricting this field of research (Shi et al. , 2025). Future Directions and Research Integrated multigenomics technologies could allow for the development of personalised care products via identification and tracking of differential skin biomarkers combining multiple omics signatures. Altered biomarker profiles can be used as indicators of particular conditions, and returned to baseline using specific ingredients that modulate the expression of these altered components, allowing for more individualised and targeted treatment for various disorders and skin types. Furthermore, understanding individual skin biomarkers can be used to predict the suitability of products for specific individuals, permitting more precise and refined product formulation (Dessì et al. , 2024). They can also provide added dimensionality to deciphering host-microbiome interactions by elucidating the functional role of these microbes and their mechanism of action in influencing skin condition by analysing the products they produce, how these are synthesised, and their overall effects on skin health, as well as offering deeper insight into skin disorders and how this host-microbe crosstalk influences progression (Fernández-Carro et al. , 2025). The growing availability of these omics datasets may facilitate the development of in silico  models that use machine learning to accurately predict the effects of cosmetic ingredients on the skin using existing omics data, acting as a more ethical alternative to existing animal models. Such “infotechnomics” approaches may pave the way for more rapid and accessible ingredient testing for factors like safety (toxicity) and efficacy, streamlining the product formulation process and allowing for greater standardisation (Kalicińska et al. , 2023). Lastly, integrated omics skin biomarkers can be used to monitor the progression of specific skin conditions, as well as predicting susceptibility to disease. This can further promote the development of predictive and preventative therapeutics via biomarker screening approaches for the identification of early diagnostic markers in order to develop effective, personalised treatments to mitigate or reduce the effects of various skin disorders that might emerge later in life (Wei et al. , 2024). Conclusion Omics provides an interdisciplinary approach to studying skin health and the microbiome, with research increasingly focusing on the application of these technologies for the development of personal care products and their effects on this dynamic host-microbial system. This allows for a holistic assessment of skin biomarkers and how these components can be altered by various products and external conditions, with many positive implications for product formulations and skin monitoring. However, despite providing an increased understanding of these complex biological systems, much work remains to be done to improve the accuracy and standardisation of such omics models. Improving these limitations can pave the way for the development of personalised products and treatments for various skin conditions, product testing, and preventative diagnostic therapeutics. References Bastonini, E. et al. (2025) ‘Lipidome Complexity in Physiological and Pathological Skin Pigmentation’, International Journal of Molecular Sciences, 26(14), p. 6785. Available at:   https://doi.org/10.3390/ijms26146785 . Chetty, A. and Blekhman, R. (2024) ‘Multi-omic approaches for host-microbiome data integration’, Gut Microbes, 16(1), p. 2297860. Available at:   https://doi.org/10.1080/19490976.2023.2297860 . Dessì, A. et al. (2024) ‘Integrative Multiomics Approach to Skin: The Sinergy between Individualised Medicine and Futuristic Precision Skin Care?’, Metabolites, 14(3), p. 157. Available at:   https://doi.org/10.3390/metabo14030157 . Fernández-Carro, E. et al. (2025) ‘Alternatives Integrating Omics Approaches for the Advancement of Human Skin Models: A Focus on Metagenomics, Metatranscriptomics, and Metaproteomics’, Microorganisms, 13(8), p. 1771. Available at:   https://doi.org/10.3390/microorganisms13081771 . Fukushima-Nomura, A., Kawasaki, H. and Amagai, M. (2025) ‘Integrative omics redefining allergy mechanisms and precision medicine’, Allergology International, 74(4), pp. 514–524. Available at:   https://doi.org/10.1016/j.alit.2025.08.007 . Jacques, C. et al. (2024) ‘Multi-omics approach to understand the impact of sun exposure on an in vitro skin ecosystem and evaluate a new broad-spectrum sunscreen’, Photochemistry and Photobiology, 100(2), pp. 477–490. Available at:   https://doi.org/10.1111/php.13841 . Jacques, C. et al. (2025) ‘Multi-omics analysis to evaluate the effects of solar exposure and a broad-spectrum SPF50+ sunscreen on markers of skin barrier function in a skin ecosystem model’, Photochemistry and Photobiology, 101(2), pp. 373–385. Available at:   https://doi.org/10.1111/php.14001 . Kalicińska, J. et al. (2023) ‘Artificial Intelligence That Predicts Sensitizing Potential of Cosmetic Ingredients with Accuracy Comparable to Animal and In Vitro Tests—How Does the Infotechnomics Compare to Other “Omics” in the Cosmetics Safety Assessment?’, International Journal of Molecular Sciences, 24(7), p. 6801. Available at:   https://doi.org/10.3390/ijms24076801 . Li, M. et al. (2023) ‘Multi-omic approach to decipher the impact of skincare products with pre/postbiotics on skin microbiome and metabolome’, Frontiers in Medicine, 10. Available at:   https://doi.org/10.3389/fmed.2023.1165980 . Liu, Yang et al. (2023) ‘Proteomics and transcriptomics explore the effect of mixture of herbal extract on diabetic wound healing process’, Phytomedicine, 116, p. 154892. Available at:   https://doi.org/10.1016/j.phymed.2023.154892 . Ning, K. and Li, Y. (2023) ‘Introduction to Multi-Omics’, in K. Ning (ed.) Methodologies of Multi-Omics Data Integration and Data Mining: Techniques and Applications. Singapore: Springer Nature, pp. 1–10. Available at:   https://doi.org/10.1007/978-981-19-8210-1_1 . Shi, S. et al. (2025) ‘The role of multiomics in revealing the mechanism of skin repair and regeneration’, Frontiers in Pharmacology, 16. Available at:   https://doi.org/10.3389/fphar.2025.1497988 . Wei, S. et al. (2024) ‘Multiomics insights into the female reproductive aging’, Ageing Research Reviews, 95, p. 102245. Available at:   https://doi.org/10.1016/j.arr.2024.102245 .

  • Vitamin C, The Microbiome Ally

    Within the skincare sector, Vitamin C has been hailed as an all-round skincare essential product with capabilities of for brightening, antioxidant protection, and collagen support however, its specific effects on the skin microbiome are only beginning to be understood.  What we know: Emerging research suggests that Vitamin C, whether taken as a supplement or applied topically, can support microbial diversity, modulate immune responses, and aid in wound healing. Topical Vitamin C, especially in low-pH formulations, increases microbial diversity without disrupting key bacteria such as Staphylococcus epidermidis  and Cutibacterium acnes (Janssens-Böcker et al,  2024). Vitamin C also has anti-inflammatory and antimicrobial properties, helping manage acne by inhibiting pathogens such as C. acnes , with effects enhanced when combined with zinc or clarithromycin (Sun et al , 2024). Vitamin C also supports the skin barrier and immune function, benefiting skin conditions such as acne, psoriasis, and dermatitis. While mechanisms in disease contexts are still being studied, evidence highlights its microbiome-friendly potential (Joshi et al,  2023). Industry Impact and Potential As microbiome-conscious skincare grows, Vitamin C offers brands opportunities to innovate responsibly. Its dual role as a skin health booster and microbiome-friendly ingredient enables effective, gentle formulations that meet demand for science-backed, sustainable products. Emerging research points to key innovation areas: Combination therapies:  Pairing Vitamin C with actives like zinc or light treatments targets pathogens, reduces inflammation, and supports repair. Personalized skincare:  Understanding Vitamin C’s interaction with individual microbiomes enables tailored products that enhance efficacy while preserving balance. Barrier and wound support:  Vitamin C-based dressings and delivery systems promote healing and antimicrobial protection without cytotoxicity. Our Solution: At Sequential, we specialise in supporting business to innovate confidently by providing comprehensive microbiome product testing. With a database of 50,000+ microbiome samples, 4,000 ingredients, and 10,000+ testing participants, we deliver science-driven, actionable insights that can help guide product formulation. With our expertise and customisable services, we can support the creation of products that not only deliver visible results but also support a healthy and balanced microbiome for long term skin viability. References: Janssens-Böcker, C., Doberenz, C., Monteiro, M., & De Oliveira Ferreira, M., 2024. Influence of Cosmetic Skincare Products with pH < 5 on the Skin Microbiome: A Randomized Clinical Evaluation.  Dermatology and Therapy , 15, pp. 141 - 159. https://doi.org/10.1007/s13555-024-01321-x . Joshi, M., Hiremath, P., John, J., Ranadive, N., Nandakumar, K., & Mudgal, J., 2023. Modulatory role of vitamins A, B3, C, D, and E on skin health, immunity, microbiome, and diseases.  Pharmacological Reports , 75, pp. 1096 - 1114. https://doi.org/10.1007/s43440-023-00520-1 . Sun, C., Na, Y., Wang, Z., Zhu, T., & Liu, X., 2024. Phytochemicals, promising strategies combating Cutibacterium acnes.  Frontiers in Pharmacology , 15. https://doi.org/10.3389/fphar.2024.1476670 .

bottom of page